期刊文献+

卵巢癌化疗后感染现状和影响因素分析 被引量:2

Study on infection status and influential factors of ovarian cancer patients after chemotherapy
原文传递
导出
摘要 目的探讨卵巢癌患者化疗后感染现状和影响因素。方法选取2011年1月至2013年1月收治的302例卵巢癌患者的临床资料,进行描述性统计和二分类Logistic回归分析。结果卵巢癌患者化疗后感染发生率为10.6%(32/302),以上呼吸道感染最多见(37.5%),多因素Logistic回归分析发现,高龄(OR=7.692,P=0.000)、侵入性操作多(OR=13.074,P=0.000)、白细胞数低(OR=15.864,P=0.000)和住院时间>21天(OR=10.033,P=0.000)是卵巢癌患者化疗后感染的影响因素。结论卵巢癌患者化疗后感染发生率较高,其发生受多方面因素影响。 Objective To investigate the infection status and influential factors of ovarian cancer patients after chemotherapy. Methods The clinical data of 302 ovarian cancer patients who were treated in our hospital from January 2011 to January 2013 were collected, and analyzed by descriptive statistics and binary classification logistic regression analysis. Results The infection rate of ovarian cancer patients was 10. 6% (32/302) , the most common infection was upper respiratory infection (37.5%). Multiple logistic regression analysis showed that venerable age (OR = 7. 692, P =0. 000), more invasive operations (OR = 13. 074, P =0. 000) , low white blood cell count (OR = 15. 864, P =0. 000) and hospital stay 〉 21 days ( OR = 10. 033, P = 0. 000) were major risk factors of ovarian cancer patients. Conclusions Ovarian canc- er patients treated with chemotherapy were under a considerable high infection rate, which was affected by various factors.
作者 曹文静
出处 《中国肿瘤临床与康复》 2013年第9期953-955,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 卵巢肿瘤 药物疗法 感染 影响因素 横断面调查 Ovarian neoplasms Drug therapy Infection Influential factors Cross-sectional survey
  • 相关文献

参考文献8

  • 1Rosa MI, Silva GD, de Azedo Sim6es PW, et al. The prevalence of human papillomavirus in ovarian cancer: a systematic review [ J]. Int J Gynecol Cancer, 2013, 23:437-441.
  • 2Kwon MJ, Shin YK. Regulation of ovarian cancer stem cells or tumor-initiating cells [J]. Int J Mol Sci, 2013, 14:6624-6648.
  • 3Gupta D, Braun DP, Staren ED, et al. Longitudinal health-related quality of life assessment: implications for prognosis in ovarian cancer[J]. J Ovarian Res, 2013, 6:17.
  • 4Vargas-Hemdndez VM. Endometriosis as a risk factor for ovarian cancer[J]. Cir Cir, 2013, 81:153-168.
  • 5Freitag P. Follow-up after the treatment of ovarian cancer - really without Ca 125? [ J]. Ceska Gynekol, 2012, 77:540-542.
  • 6Menczer J. Conservative fertility-sparing surgical treatment of in- vasive epithelial ovarian cancer: when is it acceptable? [ J ]. Isr Med Assoc J, 2013, 15:116-120.
  • 7Munksgaard PS, Blaakaer J. The association between endometrio- sis and ovarian cancer:a review of histological, genetic and mo- lecular alterations [ J ]. Gynecol Oncol, 2012, 124 : 164-169.
  • 8Worley MJ,Welch WR, Berkowitz RS, et al. Endometriosis-associated ovarian cancer: a review of pathogenesis [J]. Int J Mol Sci, 2013, 14:5367-5379.

同被引文献23

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部